COMMENTARY
Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report
F. Stephen Hodi, Scott Granter, and Joseph Antin
Cancer Immunity 5 : 7 (19 May 2005) >Full text >PDF

ARTICLE
The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases
Yvonne M. Saenger and Jedd D. Wolchok
Cancer Immunity 8 : 1 (17 January 2008) >Abstract >Full text >PDF

COMMENTARY
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain
Verena Voelter, Alessia Pica, Julien Laurent, Donata Rimoldi, Hanifa Bouzourene, Ali Sajadi, Maurice Matter, Pedro Romero, Nathalie Rufer and Daniel E. Speiser
Cancer Immunity 8 : 6 (27 March 2008) >Full text >PDF

ARTICLE
Concurrent decrease in IL-10 with development of immune-related adverse events in a patient treated with anti-CTLA-4 therapy
Jingjing Sun, Jade Schiffman, Anitha Raghunath, Derek Ng Tang, Hong Chen and Padmanee Sharma
Cancer Immunity 8 : 9 (27 May 2008) >Abstract >Full text >PDF

ARTICLE
Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient
Midori Isobe, Shingo Eikawa, Akiko Uenaka, Yoichi Nakamura, Tetsuo Kanda, Shigeru Kohno, Kiyotaka Kuzushima and Eiichi Nakayama
Cancer Immunity 9 : 8 (1 October 2009) >Abstract >Full text >PDF

ARTICLE
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy
Jianda Yuan, David B. Page, Geoffrey Y. Ku, Yanyun Li, Zhenyu Mu, Charlotte Ariyan, Humilidad F. Gallardo, Ruth-Ann Roman, Agnes I. Heine, Stephanie L. Terzulli, Sacha Gnjatic, Gerd Ritter, Achim A. Jungbluth, James P. Allison, Lloyd J. Old and Jedd D. Wolchok
Cancer Immunity 10 : 1 (7 January 2010) >Abstract >Full text >PDF >Erratum